# A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures

> **NCT02364791** · PHASE2 · UNKNOWN · sponsor: **National Cancer Institute, Naples** · enrollment: 120 (estimated)

## Conditions studied

- Thoracic Surgery Lung
- Post-operative Thoracic Air Leak

## Interventions

- **DEVICE:** standard techniques used to achieve air leak control
- **DEVICE:** Hemopatch

## Key facts

- **NCT ID:** NCT02364791
- **Lead sponsor:** National Cancer Institute, Naples
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-03-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02364791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02364791, "A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02364791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*